-
DARWIN EU®: EMA selected first data partners
DARWIN EU®: EMA selected first data partners
-
DARWIN EU®: EMA selected first data partners
DARWIN EU®: EMA selected first data partners
Collaboration will help generate real-world evidence that can support scientific evaluations and regulatory decision-making for medicines
-
New Quality Innovation Expert Group
New Quality Innovation Expert Group
-
New Quality Innovation Expert Group
New Quality Innovation Expert Group
EMA established a Quality Innovation Expert Group (QIG) to support innovative approaches for the development, manufacture, and quality control of medicines
-
EMA's response to monkeypox
EMA's response to monkeypox
-
EMA's response to monkeypox
EMA's response to monkeypox
Find out about monkeypox disease, medicines available in the EU to tackle it and how EMA and its EU partners are helping to combat the outbreak
-
Monthly safety updates for COVID-19 vaccines
Monthly safety updates for COVID-19 vaccines
-
Monthly safety updates for COVID-19 vaccines
Monthly safety updates for COVID-19 vaccines
EMA has released safety update reports on all COVID-19 vaccines authorised in the EU. They provide an overview of the safety monitoring of these vaccines
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal